RNTX Q1 2026 Earnings EPS Beats Estimates as Preclinical Stage Biotech Tightens Spending Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings EPS Misses Estimates as Biotech Focuses on Clinical Pipeline FICO Q1 2026 Earnings EPS Surges Past Expectations Amid Strong Scoring Business BMBL Q1 2026 Earnings EPS Surges Past Estimates with 224 Beat FVRR Q1 2026 Earnings EPS Misses Estimate Stock Gains Despite Narrow Beat AEHL Q3 2012 Earnings EPS Beats Estimates by 768 Stock Falls Sharply